Browsing Tag
Voyager Acquisition Corp.
1 post
VERAXA has a $27.5m note and $50m funding facility. Why is Raju Willener becoming CFO now?
VERAXA Biotech has appointed capital-markets veteran Raju Willener as chief financial officer less than three months after its Nasdaq debut, with oncology programmes moving toward clinical development and financing strategy becoming increasingly important.